Clinical Trials Directory

Trials / Completed

CompletedNCT00837850

SmartSet HV and Palacos R RSA Bone Cements in Primary Total Hip Arthroplasty

A Randomised Prospective Trial of SmartSet HV and Palacos R Bone Cements in Primary Total Hip Arthroplasty. A Radiostereometric Analysis of the Charnley Femoral Component.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
35 (actual)
Sponsor
Norwegian University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 78 Years
Healthy volunteers
Not accepted

Summary

A randomised radiostereometric study comparing SmartSet HV and Palacos R acrylic bone cements.

Detailed description

The fixation of components in total hip arthroplasty has a significant effect on the long-term survival of the prostheses. Bone cement in total joint replacement acts as an anchoring medium for the prosthesis and provides a barrier to the ingress of wear debris into bone surfaces. However, there are significant differences in cement behaviour among differing types of cement. A clinical study based on the Norwegian Arthroplasty Register demonstrated that there is an increased rate of revision due to aseptic loosening of femoral components implanted with low-viscosity cement compared with that of high-viscosity. Studies have shown that high early migration for certain designs of femoral prosthesis can be a predictor for clinical loosening. RSA is a technique enabling calculation of the three-dimensional translational and rotational movements of the implant relative to the bone, and therefore provides an ideal technique to detect early micromotion of implants.

Conditions

Interventions

TypeNameDescription
DEVICEBone cement 1Bone cement SmartSet® HV
DEVICEBone cement 2Bone cement Palacos R

Timeline

Start date
2002-10-01
Primary completion
2003-10-01
Completion
2008-10-01
First posted
2009-02-05
Last updated
2011-08-26

Source: ClinicalTrials.gov record NCT00837850. Inclusion in this directory is not an endorsement.